Skip to main content
Jin Medical International Ltd. (ZJYL)
NASDAQ: ZJYL · Real-Time Price · USD
0.152
+0.006 (4.33%)
At close: Mar 9, 2026, 4:00 PM EDT
0.154
+0.002 (1.25%)
Pre-market: Mar 10, 2026, 4:00 AM EDT

Jin Medical International Revenue

In the fiscal year ending September 30, 2025, Jin Medical International had annual revenue of $20.69M, down -11.98%. Jin Medical International had revenue of $10.81M in the half year ending September 30, 2025, with 12.93% growth.

Revenue (ttm)
$20.69M
Revenue Growth
-11.98%
P/S Ratio
1.17
Revenue / Employee
$75,778
Employees
273
Market Cap
23.76M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Sep 30, 202520.69M-2.81M-11.98%
Sep 30, 202423.50M3.68M18.57%
Sep 30, 202319.82M630.92K3.29%
Sep 30, 202219.19M-1.57M-7.58%
Sep 30, 202120.76M4.57M28.22%
Sep 30, 2020 Pro Pro Pro
Sep 30, 2019 Pro Pro Pro
Sep 30, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Harvard Bioscience 87.37M
Retractable Technologies 37.90M
Bionano Genomics 28.72M
Precision Optics Corporation 24.42M
Nephros 17.93M
Ekso Bionics Holdings 12.80M
NEXGEL 11.67M
Milestone Scientific 8.93M
Revenue Rankings

ZJYL News

More News